Profile
David K.
Y.
Poon is currently the Director at LifeSciences British Columbia and the Chief Business Officer at Gandeeva Therapeutics, Inc. He previously worked as the Manager-Business Development at Zymeworks BC, Inc. from 2007 to 2019.
He holds a doctorate degree from the University of British Columbia.
David Poon active positions
| Companies | Position | Start |
|---|---|---|
LifeSciences British Columbia
LifeSciences British Columbia BiotechnologyHealth Technology Supports and represents the biotechnology and greater life sciences community of Britsh Columbia | Director/Board Member | 2023-09-11 |
Gandeeva Therapeutics, Inc.
Gandeeva Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a precision biotechnology company that develops therapeutics | Corporate Officer/Principal | - |
Former positions of David Poon
| Companies | Position | End |
|---|---|---|
Zymeworks BC, Inc.
Zymeworks BC, Inc. BiotechnologyHealth Technology Develops protein therapeutics for the treatment of cancer, autoimmune and inflammatory diseases | Corporate Officer/Principal | - |
Training of David Poon
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 4 |
|---|---|
Zymeworks BC, Inc.
Zymeworks BC, Inc. BiotechnologyHealth Technology Develops protein therapeutics for the treatment of cancer, autoimmune and inflammatory diseases | Health Technology |
University of British Columbia
University of British Columbia Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
LifeSciences British Columbia
LifeSciences British Columbia BiotechnologyHealth Technology Supports and represents the biotechnology and greater life sciences community of Britsh Columbia | Health Technology |
Gandeeva Therapeutics, Inc.
Gandeeva Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a precision biotechnology company that develops therapeutics | Commercial Services |
- Stock Market
- Insiders
- David Poon
















